Live Breaking News & Updates on டேவிட் கிளேர்|Page 5

Stay updated with breaking news from டேவிட் கிளேர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bio-Techne and 908 Devices Announce Joint Collaboration


Share this article
Share this article
MINNEAPOLIS and BOSTON, May 4, 2021 /PRNewswire/  Bio-Techne Corporation (NASDAQ: TECH) and 908 Devices (NASDAQ: MASS) today announced a joint collaboration to develop an extended workflow solution for protein characterization. Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and owner of the leading ProteinSimple branded protein analysis portfolio of products, will pair its Maurice icIEF separation instrument with 908 Devices ZipChip device to deliver a seamless workflow for deeper protein characterization. Maurice and the iCE technology are the gold standard in protein characterization, providing absorbance and native fluorescence icIEF detection as well as CE-SDS, saving significant development time and reducing the time to commercialization.  ....

United States , Dave Eansor , Carrie Mendivil , Kevinj Knopp , David Clair , Emily Fang , Corporate Development , Bio Techne Protein Sciences Segment , Thermo Fisher , Bio Techne Corporation , Capillary Electrophoresis , Protein Sciences , Techne Corporation , Relations Contact , Senior Director , Investor Relations , Health Care Amp Hospitals , Medical Pharmaceuticals , ஒன்றுபட்டது மாநிலங்களில் , டேவிட் கிளேர் , எமிலி ஃப்யாஂக் , பெருநிறுவன வளர்ச்சி , உயிர் தொழில்நுட்பம் ப்ரோடீந் அறிவியல் பிரிவு , தெர்மோ மீனவர் , உயிர் தொழில்நுட்பம் நிறுவனம் , ப்ரோடீந் அறிவியல் ,

Bio-Techne Announces Commercial Release of Novel DNAscope™ in situ Hybridization Assays for Chromogenic Detection of DNA Copy Number and Structural Variations


MINNEAPOLIS, April 27, 2021 /PRNewswire/ Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope™ technology with release of new DNAscope Assays. The RNAscope technology is an advanced
in situ hybridization (ISH) assay that enables visualization of single-molecule gene expression with single-cell resolution directly in intact cells and tissues.
Bio-Techne s new chromogenic DNA
in situ hybridization (ISH) technology, DNAscope, employs the proven double-Z probe design and signal amplification system of RNAscope, enabling rapid and flexible probe development for any DNA target, enabling visualization of targets in formalin-fixed paraffin-embedded (FFPE) tissues. DNAscope delivers benefits over current commercial FISH techniques that fall short on morphological detail due to the use of fluorescent nuclear staining and rely on high-resolution microscopes to visualize gene rearrangemen ....

Kim Kelderman , David Clair , Prnewswire Bio Techne Corporation , Research Use , Corporate Development , Bio Techne Corporation , Techne Corporation , Advanced Cell Diagnostics , Bacterial Artificial Chromosome , Senior Director , Investor Relations , கிம் கேள்தேர்மன் , டேவிட் கிளேர் , ஆராய்ச்சி பயன்பாடு , பெருநிறுவன வளர்ச்சி , உயிர் தொழில்நுட்பம் நிறுவனம் , தொழில்நுட்பம் நிறுவனம் , பாக்டீரியா செயற்கை குரோமோசோம் , மூத்தவர் இயக்குனர் , முதலீட்டாளர் உறவுகள் ,

Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis


MINNEAPOLIS, April 15, 2021 /PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne brand, completed an extensive rebranding effort in response to increased demand for its Assay Services offered at its Newark, CA laboratory. At the heart of this re-launch is a name change from Pharma Assay Services to Professional Assay Services, with an expansion of offerings to global academic and clinical institutions, building on 10 years of experience providing services to our global pharma and biotech partners. Bio-Techne s Professional Assay Services provide
in situ hybridization (ISH) gene expression analysis for target discovery, biomarker validation, drug safety assessment, and assay prototype development directly from the RNAscope™ technology experts. ....

Kim Kelderman , David Clair , Prnewswire Bio Techne Corporation , Assay Services , Investor Relations Corporate Development , Good Clinical Laboratory Practices , World Health Organization , Pharma Assay Services To Professional , Bio Techne Corporation , Techne Corporation , Advanced Cell Diagnostics , Pharma Assay Services , Professional Assay Services , World Health , Senior Director , Investor Relations , கிம் கேள்தேர்மன் , டேவிட் கிளேர் , மதிப்பீடு சேவைகள் , முதலீட்டாளர் உறவுகள் பெருநிறுவன வளர்ச்சி , நல்ல மருத்துவ ஆய்வகம் ப்ர்யாக்டிஸஸ் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , உயிர் தொழில்நுட்பம் நிறுவனம் , தொழில்நுட்பம் நிறுவனம் , உலகம் ஆரோக்கியம் , மூத்தவர் இயக்குனர் ,

Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis

Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis